Contribution of xanthine oxidoreductase to mammary epithelial and breast cancer cell differentiation in part modulates inhibitor of differentiation-1

Molecular Cancer Research

Volumn 9, Issue 9, 2011, Pages 1242-1254

  Fini, Mehdi A ^a,b   Monks, Jenifer ^a,b   Farabaugh, Susan M ^b   Wright, Richard M ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CELL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INHIBITOR OF DIFFERENTIATION 1; OXIPURINOL; TUMOR MARKER; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER CELL DESTRUCTION; CANCER RELAPSE; CELL DIFFERENTIATION; CELL PROLIFERATION; DATA ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENES, ERBB-2; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MAMMARY GLANDS, HUMAN; MICE; MICE, INBRED C57BL; MICE, NUDE; MICROARRAY ANALYSIS; RNA, SMALL INTERFERING; XANTHINE DEHYDROGENASE;

EID: 80052834039     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0176     Document Type: Article

References (50)

1. Linder N, Lundin J, Isola J, Lundin M, Raivio KO, Joensuu H. Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer. Clin Cancer Res 2005;11:4372-81. (Pubitemid 40825626)
2. Cook WS, Chu R, Saksela M, Raivio KO, Yelandi A. V. Differential immunohistochemical localization of xanthine oxidase in normal and neoplastic human breast epithelium. Int J Oncol 1997;11:1013-7. (Pubitemid 27439408)
3. Lewin I, Lewin R, Bray RC. Xanthine oxidase activity during mammary carcinogenesis in mice. Nature 1957;180:763-4.
4. Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET, et al. cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]-anthracene. Carcinogenesis 2002;23:1561-8.
5. Fini MA, Orchard-Webb D, Kosmider B, Amon JD, Kelland R, Shibao G, et al. Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase. J Cell Biochem 2008;105:1008-26.
6. McManaman JL, Hanson L, Neville MC, Wright RM. Lactogenic hormones regulate xanthine oxidoreductase and beta-casein levels in mammary epithelial cells by distinct mechanisms. Arch Biochem Biophys 2000;373:318-27. (Pubitemid 30068969)
7. Linder N, Rapola J, Raivio KO. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Invest 1999;79:967-74. (Pubitemid 29400141)
8. Garattini E, Mendel R, Romao MJ, Wright R, Terao M. Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem J 2003;372:15-32. (Pubitemid 36609603)
9. Anderson SM, Rudolph MC, McManaman JL, Neville MC. Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis! Breast Cancer Res 2007;9:204.
10. Kurosaki M, Zanotta S, Li Calzi M, Garattini E, Terao M. Expression of xanthine oxidoreductase in mouse mammary epithelium during pregnancy and lactation: regulation of gene expression by glucocorticoids and prolactin. Biochem J 1996;319:801-10. (Pubitemid 26386193)
11. McManaman JL, Neville MC, Wright RM. Mouse mammary gland xanthine oxidoreductase: purification, characterization, and regulation. Arch Biochem Biophys 1999;371:308-16.
12. McManaman JL, Palmer CA, Wright RM, Neville MC. Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion. J Physiol 2002;545:567-79. (Pubitemid 36004390)
13. Seymour KJ, Roberts LE, Fini MA, Parmley LA, Oustitch TL, Wright RM. Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta. J Biol Chem 2006;281:8545-58. (Pubitemid 43847957)
14. Vorbach C, Scriven A, Capecchi MR. The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland. Genes Dev 2002;16:3223-35. (Pubitemid 36025975)
15. Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 2005;26:1393-9.
16. Ohtsubo T, Rovira II, Starost MF, Liu C, Finkel T. Xanthine oxidoreductase is an endogenous regulator of cyclooxygenase-2. Circ Res 2004;95:1118-24. (Pubitemid 39557899)
17. Shin MH, Moon YJ, Seo JE, Lee Y, Kim KH, Chung JH. Reactive oxygen species produced by NADPH oxidase, xanthine oxidase, and mitochondrial electron transport system mediate heat shock-induced MMP-1 and MMP-9 expression. Free Radic Biol Med 2008;44:635-45. (Pubitemid 351181264)
18. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436:518-24. (Pubitemid 41112921)
19. Perk J, Gil-Bazo I, Chin Y, de Candia P, Chen JJ, Zhao Y, et al. Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res 2006;66:10870-7. (Pubitemid 44876984)
20. Terao M, Cazzaniga G, Ghezzi P, Bianchi M, Falciani F, Perani P, et al. Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase. Regulation of its transcript by interferons in vivo. Biochem J 1992;283:863-70.
21. Noren NK, Foos G, Hauser CA, Pasquale EB. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 2006;8:815-25. (Pubitemid 44151584)
22. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 2009;11:R32.
23. Tanaka T, Doi K, Maeda-Mamiya R, Negishi K, Portilla D, Sugaya T, et al. Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. Am J Pathol 2009;174:1203-11.
24. Wu X, Wakamiya M, Vaishnav S, Geske R, Montgomery C Jr, Jones P, et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A 1994;91:742-6. (Pubitemid 24041478)
25. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989;24:148-54. (Pubitemid 19163397)
26. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 2004;6:R75-91.
27. Rudolph MC, McManaman JL, Hunter L, Phang T, Neville MC. Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution. J Mammary Gland Biol Neoplasia 2003;8:287-307. (Pubitemid 39137512)
28. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymphnode- negative primary breast cancer. Lancet 2005;365:671-9. (Pubitemid 40260888)
29. Hynes NE, Taverna D, Harwerth IM, Ciardiello F, Salomon DS, Yamamoto T, et al. Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells. Mol Cell Biol 1990;10:4027-34.
30. Kim A, Liu B, Ordonez-Ercan D, Alvarez KM, Jones LD, McKimmey C, et al. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells. Breast Cancer Res 2005;7:R708-18.
31. Ling MT, Wang X, Zhang X, Wong YC. The multiple roles of Id-1 in cancer progression. Differentiation 2006;74:481-7. (Pubitemid 44922493)
32. Fong S, Debs RJ, Desprez PY. Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 2004;10:387-92. (Pubitemid 39061140)
33. Desprez PY, Sumida T, Coppe JP. Helix-loop-helix proteins in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2003;8:225-39. (Pubitemid 38129944)
34. Sellappan S, Grijalva R, Zhou X, Yang W, Eli MB, Mills GB, et al. Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 2004;64:3479-85. (Pubitemid 38657921)
35. Whyte J, Bergin O, Bianchi A, McNally S, Martin F. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res 2009;11:209.
36. Myers AP, Cantley LC. Targeting a common collaborator in cancer development. Sci Transl Med 2010;2:48ps45.
37. Yang W, Ju JH, Lee KM, Shin I. Akt isoform-specific inhibition of MDAMB- 231 cell proliferation. Cell Signal 2011;23:19-26.
38. Mester J, Redeuilh G. Proliferation of breast cancer cells: regulation, mediators, targets for therapy. Anticancer Agents Med Chem 2008;8:872-85.
39. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007;26:3279-90. (Pubitemid 46763021)
40. Andersen JN, Sathyanarayanan S, Di Bacco A, Chi A, Zhang T, Chen AH, et al. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors. Sci Transl Med 2010;2:43ra55.
41. Li B, Tsao SW, Li YY, Wang X, Ling MT, Wong YC, et al. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer 2009;125:2576-85.
42. Lee JY, Kang MB, Jang SH, Qian T, Kim HJ, Kim CH, et al. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene 2009;28:824-31.
43. Mori S, Nishikawa SI, Yokota Y. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO J 2000;19:5772-81.
44. Itahana Y, Singh J, Sumida T, Coppe JP, Parrinello S, Bennington JL, et al. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells. Cancer Res 2003;63:7098-105. (Pubitemid 37413446)
45. Nair R, Junankar S, O'Toole S, Shah J, Borowsky AD, Bishop JM, et al. Redefining the expression and function of the inhibitor of differentiation 1 in mammary gland development. PLoS One 2010; 5:e11947.
46. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A 2007;104:19506-11.
47. Uehara N, Chou YC, Galvez JJ, de-Candia P, Cardiff RD, Benezra R, et al. Id-1 is not expressed in the luminal epithelial cells of mammary glands. Breast Cancer Res 2003;5:R25-9.
48. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 2000;60:1332-40. (Pubitemid 30152003)
49. Budhiraja R, Kayyali US, Karamsetty M, Fogel M, Hill NS, Chalkley R, et al. Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism. Antioxid Redox Signal 2003;5:705-11. (Pubitemid 37462053)
50. Taibi G, Carruba G, Miceli V, Cocciadiferro L, Nicotra CM. Estradiol decreases xanthine dehydrogenase enzyme activity and protein expression in non-tumorigenic and malignant human mammary epithelial cells. J Cell Biochem 2009;108:688-92.